Skip to main content Skip to main navigation menu Skip to site footer
Articles
Published: 2020-11-24

To which extent a convalescent plasma therapy could be a benefit for COVID-19 patients?

Department of Clinical Chemistry, College of Medical laboratory science, AL- Neelain University, Sudan
Department of Clinical Chemistry, College of Medical laboratory science, AL- Neelain University, Sudan
Department of Clinical Chemistry, College of Medical laboratory science, AL- Neelain University, Sudan
Department of Hematology, College of Medical laboratory science, University of Alzaiem Al Azhari, Sudan
Department of Microbiology, College of Medical laboratory science, University of Alzaiem Al Azhari, Sudan
Department of Clinical Chemistry, College of Medical laboratory science, Al Gezera University, Sudan
Department of Hematology and Immunohematology, Sudan University of Science and Technology, Sudan
Department of Medical Microbiology, College of Medical Laboratory Science, Al Gezera University, Sudan
Convalescence plasma, COVID-19, Transfusion, Neutralizing Antibodies

Abstract

The emergence of an unprecedented pandemic SARS-COV-2 caused perplexed in the medical community because of a high infection rate and rising mortality among COVID-19 patients. Till now, there is no particular treatment for the disease; nevertheless, there is an extensive effort from scientists to find out an immediate therapeutic plan to show how to deal with the current situation. One of the solutions currently presented is Convalescence plasma (CP). Through this narrative review, we will shed light on CP's efficiency as a therapeutic agent for COVID-19, especially there is no proven vaccine or antiviral available up to date. CP could be considered one of the therapeutic approaches, but some limitations are still considered before it is established as a therapeutic agent. Along with evaluating CP from blood donors, the plasma companies could take future steps by manufacturing a target dose of globulins that contain standardized antibody, to reach the terms of health setting administering therapy.



Downloads

Download data is not yet available.


How to Cite

1.
Ali A, Abuelhassan A, Fawzi E, Albasher A, Elbasheer S, Suliman N, Elhussein A, Ali M. To which extent a convalescent plasma therapy could be a benefit for COVID-19 patients?. jidhealth [Internet]. 2020 Nov. 24 [cited 2022 May 19];3(4):254-7. Available from: https://jidhealth.com/index.php/jidhealth/article/view/79